NCT03368404View on ClinicalTrials.gov

A Study to Evaluate the Performance and Safety of CBL-102 Versus Vismed® Multi Eye Drops in the Management of Dry Eye

NACompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

November 9, 2017

Primary Completion Date

June 2, 2020

Study Completion Date

June 2, 2020

Conditions
Dry Eye
Interventions
DEVICE

CBL-102 eye drops

CBL-102 eye drops, 3 to 6 times per day for 3 months

DEVICE

Vismed Multi eye drops

Vismed Multi eye drops, 3 to 6 times per day for 3 months

Trial Locations (1)

94270

Hôpital Kremlin-Bicêtre, Le Kremlin-Bicêtre

Sponsors
All Listed Sponsors
collaborator

Bausch & Lomb Incorporated

INDUSTRY

lead

Laboratoire Chauvin

INDUSTRY